Healthcare's Leadership Churn: A Wave of CEO and Executive Transitions Reshapes the Industry

When a health system changes its CEO, most patients never notice. They still show up for their appointments, still get their prescriptions filled, still wait in the same exam rooms. But leadership transitions like the ones sweeping through healthcare this September carry weight well beyond the executive suite. They shape which communities get investment, which populations get prioritized, and whether an organization's mission survives its next chapter.

This month's reshuffling is unusually dense. Nonprofit hospitals, national insurers, and specialty research institutions are all handing off the reins at once, and the pattern says something about where the industry is headed: toward leaders steeped in finance, data and AI, often promoted from within rather than recruited from outside.

Take ChristianaCare, the Wilmington, Delaware-based nonprofit teaching system. Jenn Schwartz became its new president and CEO on September 1, succeeding Janice Nevin, M.D., who is retiring after 23 years with the organization and a dozen years running it. Nevin joined as chair of family and community medicine and is credited by the board with expanding the system's footprint and steering "significant investment in historically under-resourced areas," language that matters in a sector where access gaps often track along income and race. Schwartz, who joined ChristianaCare in 2018 as chief legal officer after more than a decade at Lourdes Health System, was named executive vice president and chief strategy officer earlier this year before stepping into the top job.

That kind of internal grooming shows up again and again this cycle. At St. Jude Children's Research Hospital, Charles W.M. Roberts, M.D., Ph.D., will become president and CEO effective January 1, 2027, taking over from James R. Downing, M.D., who announced in February he would step down. Roberts has directed the St. Jude Comprehensive Cancer Center since 2015, pushing it to its best-ever National Cancer Institute rankings and contributing research that helped pave the way for FDA-approved cancer therapies. The hospital says it ran "an extensive international search" before ultimately choosing someone already inside the building.

Summa Health, meanwhile, looked outside. Jennifer Eslinger will become the Ohio system's president and CEO on September 21, replacing Daryl Tol, who has served as acting CEO since the organization's acquisition by Health Assurance Transformation Company. Eslinger spent more than two decades in healthcare leadership, most recently as president and COO of Rochester Regional Health, where she guided a $4.2 billion system through what the board called significant transformation.

The Insurance and Finance Reshuffle

Insurers are undergoing their own leadership churn, and much of it centers on technology and money.

Centene named Bradley Bolivar as chief information officer effective August 31, replacing Brian LeClare, who retires in October. Bolivar spent decades in technology leadership, including a stint as CIO at Fannie Mae. CEO Sarah London framed the hire around AI's growing role in the business, saying data and technology are becoming "strategic capabilities that shape how we operate, innovate and create value." Centene is also losing its CFO. Drew Asher will step down in December and retire at the end of 2027, staying on for a year to help with the transition. His successor, Chris Neczypor, currently CFO at Lincoln Financial, joins in September after more than a decade in financial services, including time as an equity research analyst at Goldman Sachs.

Elevance Health tapped Patrick Fox, M.D., as president of Carelon Behavioral Health, drawing on his three decades in clinical psychiatry, behavioral health and health plan leadership. Fox most recently led Wellpoint New Jersey. Kristy Duffey, president of Carelon Health, said his combined clinical and operational background "will be invaluable as we work to improve access." Patrick Gillespie, Elevance's regional vice president for state affairs, moves up to fill Fox's old seat at Wellpoint New Jersey.

Humana added two significant hires. Shantanu Nundy, M.D., currently executive vice president of care delivery and chief health officer at Accolade, becomes Humana's chief medical officer on August 31, reporting directly to CEO Jim Rechtin. Nundy has also advised the FDA and World Bank on digital health and AI, and he still practices primary care at a community health center. Separately, James Holland joins Humana as senior vice president and president of Medicaid on August 17, taking responsibility for plans covering 1.6 million people across 11 states. Holland comes from Johns Hopkins Health Plans and previously worked at Elevance Health, Amerigroup and WellCare.

Providence St. Joseph Health, the West Coast nonprofit system, named Kevin Smith as its new CFO effective October 26. Smith arrives from SSM Health, where he currently serves as CFO, and has also held finance roles at Luminis Health, Lehigh Valley Health Network, Universal Health Services and the University of Pennsylvania Health System.

Tufts Medicine is losing both its CEO and CFO amid what the system describes as a financial strengthening effort. Mike Dandorph will step down September 30, the end of the fiscal year, after six and a half years leading the organization. Phil Okala, currently Tufts' COO, will serve as acting president and CEO. CFO Andrew DeVoe is also departing, with Greg Kruse, Tufts' vice president of strategic operations and analytics intelligence, taking over budget planning while a national search begins.

At Kaiser Permanente's Risant Health, Jaewon Ryu is stepping down as CEO to focus on family, with Dale Maxwell, former president and CEO of Presbyterian Healthcare Services, stepping in as interim leader. Ryu built Risant's operating model from scratch and oversaw the additions of Geisinger and Cone Health during his tenure.

Why It Matters

These moves are not just corporate housekeeping. They shape who decides where hospitals invest, which patient populations get attention, and how quickly organizations adopt new technology like AI-driven data systems. When a CEO with two decades in Medicaid oversight steps into a new insurance role, or when a behavioral health veteran takes charge of a major mental health division, those backgrounds inform real decisions about access and care quality for millions of people. Watching who rises, and who steps back, tells us something honest about where the healthcare industry believes its future lies.